Wed. 7 Feb 2024, 5:02pm ET
Benzinga
Earnings, Earnings Misses, News
Ascendis Pharma (NASDAQ:ASND) reported quarterly losses of $(1.66) per share which missed the analyst consensus estimate of $(1.59) by 4.4 percent. The company reported $148.22 million in sales this quarter. This is a 534.24 percent increase over sales of $23.37 million the same period last year.